XEOMIN® Dosing | Pediatric Patients with Chronic Sialorrhea

XEOMIN is the First and Only FDA-Approved Neuromodulator For Pediatric Patients With Chronic Sialorrhea

Dosing Sites Focus on 2 Key Glands1

Table showing dosing recommendations for XEOMIN®. Pinch to zoom
  • Recommended dose: based on body weight administered in a 3:2 dose ratio into the parotid and submandibular glands, respectively, no sooner than every 16 weeks1

Where to Inject

  • Click here to download the muscle injection tracker
Where to inject XEOMIN®. Pinch to zoom

Reference

  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2020.